Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Lower urinary tract symptoms of neurological origin in urological practice.
TH17 cell differentiation is regulated by the circadian clock.
Practical medical applications of quantitative MR relaxometry.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression.
Pediatric Multiple Sclerosis.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Fat-soluble vitamins as disease modulators in multiple sclerosis.
Cortico-juxtacortical involvement increases risk of epileptic seizures in multiple sclerosis.
Occupational Exposure and Risk of Central Nervous System Demyelination.
[Factorial structure of the dysexecutive questionnaire in a sample of the Spanish population with acquired brain injury and memory deficit complaints].
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Substance Name: ONO 4641
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Tenascins and inflammation in disorders of the nervous system.
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
Alemtuzumab Therapy for Multiple Sclerosis.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.
No Help from Dalfampridine in MS-Related Optic Neuritis
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Type 1 immune response in progressive multiple sclerosis.

Pages